Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Bionomics selects BNC-210 as drug candidate for psychiatric disorders

May 30, 2007

VR1 antagonist GRC-6211 completes phase I trials in Europe

May 30, 2007

Recent patents disclose novel antipsychotic and anxiolytic agents

May 30, 2007

Novel therapeutic agents for neurological disorders disclosed in recent patents

May 30, 2007

Snapshots on biological psychiatry

May 29, 2007

Recent Abbott and Organon patents report novel analgesic agents

May 29, 2007

Phase I study under way for ABT-107

May 28, 2007

Clinical research reported at the 2007 Society of Biological Psychiatry meeting

May 28, 2007

Siena Biotech and Roche collaborate in neurodegenerative diseases

May 25, 2007

Lacosamide filed in Europe as adjunctive therapy of epilepsy

May 25, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 29, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 29, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...